… with Atrial Septal Defects
Patients diagnosed with an ASD, who are indicated for closure with an Amplatzer™ Septal Occluder, exhibit both4:
KEY FEATURES
Two Amplatzer™ ASD Closure Devices for Optimizing …
…INDUSTRY-LEADING AMPLATZER™ PDA OCCLUDERS1
The Amplatzer™ family of patent ductus arteriosus (PDA) closure occluders provides proven closure for a wide variety of patient morphologies. These devices share several…
… Life-long medication to reduce stroke risk is not an option for many patients and many reasons. The Amplatzer™ Amulet™ LAA Occluder permanently closes this primary stroke pathway without requiring these…
…THE PIONEER IN VENTRICULAR SEPTAL OCCLUDERS1
Abbott’s Amplatzer line not only pioneered structural heart defect occluders, it also retains a leadership position in structural heart innovation and treatment worldwide.1…
…PATIENTS WHO BENEFIT FROM PFO CLOSURE
The Amplatzer™ Talisman™ PFO Occluder is indicated for percutaneous transcatheter closure of a patent foramen ovale (PFO) to reduce the risk of recurrent ischemic stroke in…
…
NEW VERSION AVAILABLE GET THE AMPLATZER PORTFOLIO APP
The Amplatzer Portfolio App helps physicians determine which Amplatzer Structural Interventions device to use by suggesting applicable devices based on…
… AMPLATZER™ AMULET™ LAA OCCLUDER
STROKE RISK REDUCTION
The Amplatzer Amulet LAA Occluder is designed to treat patients with atrial fibrillation who are at risk of ischemic stroke. The device offers immediate closure1…
…
This study is evaluating the long-term safety and efficacy of the Amplatzer Septal Occluder. The results below are from 1,000 patients reported in July 2011.3
This study evaluated the initial safety and results…
